Package 51655-429-26

{"route": ["ORAL"], "spl_id": "49ed0c61-1d8f-3103-e063-6394a90a6c5b", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199888"], "spl_set_id": ["afd4c2b9-b80c-b43a-e053-2995a90ac923"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-429-26)", "package_ndc": "51655-429-26", "marketing_start_date": "20230324"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-429-52)", "package_ndc": "51655-429-52", "marketing_start_date": "20200902"}], "brand_name": "topiramate", "product_id": "51655-429_49ed0c61-1d8f-3103-e063-6394a90a6c5b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51655-429", "generic_name": "topiramate", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA078235", "marketing_category": "ANDA", "marketing_start_date": "20200902", "listing_expiration_date": "20271231"}